Brompheniramine Maleate, Pseudoephedrine Hydrochloride And Dextromethorphan Hydrobromide has 7 known drug interactions based on U.S. FDA drug labeling data. Of these, 2 are contraindicated combinations that should be avoided entirely. Notable interactions include combinations with Mao Inhibitors, Monoamine Oxidase Inhibitors (Maois), Acidifying Agents. Patients taking Brompheniramine Maleate, Pseudoephedrine Hydrochloride And Dextromethorphan Hydrobromide should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 7
- Contraindicated
- 2
- Moderate
- 4
Contraindicated (2)
- Brompheniramine Maleate, Pseudoephedrine Hydrochloride And Dextromethorphan Hydrobromide + Mao Inhibitors— Hyperpyrexia, hypotension, and death reported with coadministration. MAO inhibitors prolong/intensify anticholinergic ef…
- Brompheniramine Maleate, Pseudoephedrine Hydrochloride And Dextromethorphan Hydrobromide + Monoamine Oxidase Inhibitors (Maois)— Hyperpyrexia, hypotension, and death reported with coadministration. MAO inhibitors prolong/intensify anticholinergic ef…
Moderate (4)
- Brompheniramine Maleate, Pseudoephedrine Hydrochloride And Dextromethorphan Hydrobromide + Acidifying Agents— Antihistamine component has additive CNS depressant effects with antianxiety agents.
- Brompheniramine Maleate, Pseudoephedrine Hydrochloride And Dextromethorphan Hydrobromide + Alcohol— Antihistamine component has additive CNS depressant effects with alcohol.
- Brompheniramine Maleate, Pseudoephedrine Hydrochloride And Dextromethorphan Hydrobromide + Sedatives— Antihistamine component has additive CNS depressant effects with sedatives.
- Brompheniramine Maleate, Pseudoephedrine Hydrochloride And Dextromethorphan Hydrobromide + Tranquilizers— Antihistamine component has additive CNS depressant effects with tranquilizers.